Sources | Names Used |
---|---|
CTRPv2 | docetaxel:tanespimycin (2:1 mol/mol) |
PharmacoGx | docetaxel:tanespimycin (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | DHRS13 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | NPEPL1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
mRNA | SPEF2 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.003 |
mRNA | GART | CTRPv2 | pan-cancer | AAC | 0.099 | 0.003 |
mRNA | METTL21A | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | RPAP2 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.003 |
mRNA | PAQR4 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.003 |
mRNA | WDR44 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.003 |
mRNA | CA5B | CTRPv2 | pan-cancer | AAC | -0.097 | 0.003 |
mRNA | KIF1A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |